NEWS & REPORTS

Investor Relations

Investor Relations News

04‑03‑2018, Investors

Evonik to close its Kaba site in Hungary

Essen (Germany) / Kaba (Hungary). Evonik will stop its amino acid production at its Hungarian Kaba site by the end of April 2018. There Evonik Agroferm Zrt., a subsidiary of Evonik, currently employs about 120 people.

03‑14‑2018, Investors

Evonik plans new polyamide 12 complex in Marl

• Evonik's largest investment in Germany
• Targeted strengthening of the Resource Efficiency growth segment
• Strong growth for high-performance polymer polyamide 12 in the automotive sector, the oil and gas industry, and 3D printing

03‑06‑2018, Investors

A good performance in 2017

• Forecast fully achieved: Adjusted EBITDA of €2.36 billion is at the upper end of the range
• Outlook for 2018: Sales and earnings growth,
adjusted EBITDA between €2.4 billion and €2.6 billion
• Active portfolio management: Examining strategic options for the methacrylates business

03‑06‑2018, Investors
Evonik announces divestment of methacrylates business
02‑28‑2018, Investors
Press information of RAG-Stiftung: Dr. Werner Mueller to Step Down from Posts for Health Reasons
02‑14‑2018, Investors
Evonik opens new polyamide 12 powder plant in Marl
01‑18‑2018, Investors
Evonik and Siemens to generate high-value specialty chemicals from carbon dioxide and eco-electricity
01‑11‑2018, Investors
Evonik and Fufeng Group enter strategic partnership for the production of ThreAMINO®
12‑04‑2017, Investors
Evonik introduces new strategic structure for acrylic acid production
11‑28‑2017, Investors
Evonik to acquire high-concentrates additive compounding business from 3M
11‑15‑2017, Investors
Evonik opens new membrane production facility in Schörfling (Austria)
11‑03‑2017, Investors
Evonik optimizes structures to reduce bureaucracy and accelerate decision-making
11‑03‑2017, Investors
Evonik makes further progress in the third quarter
09‑07‑2017, Investors
Evonik again included in the Dow Jones Sustainability Indices Europe and World
08‑28‑2017, Investors
Evonik successfully acquires silica business from J.M. Huber Corporation
08‑03‑2017, Investors
Evonik on target after the first half of 2017
06‑29‑2017, Investors
Evonik successfully issues €500 million hybrid bond
06‑20‑2017, Investors
Evonik signs new syndicated credit facility totaling €1.75 billion
06‑19‑2017, Investors
C4 plant at Evonik's Antwerp site back in operation
06‑01‑2017, Investors
Building a Best-in-Class Specialty Chemicals Company
05‑10‑2017, Investors
Evonik declares Force Majeure at C4 facilities in Antwerp and Marl
05‑05‑2017, Investors
Key Financial Data: January 1 to March 31, 2017 / Q1 2017
03‑13‑2017, Investors
Evonik acquires specialist in alternative preservation systems for cosmetic products from Hamburg, Germany
03‑08‑2017, Investors
DSM and Evonik establish joint venture for omega-3 fatty acids from natural marine algae for animal nutrition
03‑02‑2017, Investors
Key Financial Data: January 1 to December 31, 2016 / Outlook for 2017
03‑01‑2017, Investors
Changes in the Executive Board
01‑03‑2017, Investors
Evonik successfully completes acquisition of Air Products specialty additives business
11‑28‑2016, Investors
Evonik to acquire technology from METEX for the fermentative production of methionine
11‑03‑2016, Investors
Evonik submits bid for METEX methionine technology platform
10‑19‑2016, Investors
Evonik starts construction of second methionine complex in Singapore
06‑21‑2016, Investors
Evonik increases the value of its innovation pipeline by half a billion euros

Contact & Service

Contacts in the Investor Relations Depart-ment

Disclaimer